主动脉瓣狭窄与冠心病的遗传风险谱存在差异
IMPORTANCE: Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist. However, it is unknown which genetic and cardiovascular risk factors might be AS-specific and which could be shared between AS and CAD.…
要点
- AS与冠心病的遗传相关性仅为0.15,提示两者遗传基础差异明显。
- 17个AS风险位点中11个为AS特异性,可作为潜在新靶点。
- 血磷升高与AS风险相关,而与冠心病无关。
核心结论
- 校正冠心病后,AS在单标记和多基因水平均呈现独特的遗传风险谱,为未来AS研究提供新靶点。
研究设计与样本
- 研究为校正冠心病的全基因组关联分析(GWAS),纳入EGAS(2000-2020年招募)、UK Biobank(2006-2010年)、Estonian Biobank(1997-2019年)和FinnGen(1964-2019年)的欧洲血统参与者。
- 另进行心血管性状GWAS与组织转录组数据的随访分析,数据分析时间为2022年10月至2023年7月。
主要发现
- 共发现17个AS风险位点,其中5个为新位点且经独立重复验证(RNF114A、AFAP1、PDGFRA、ADAMTS7、HAO1)。
- 17个位点中11个与AS风险特异性相关、与冠心病无关(ALPL、PALMD、PRRX1、RNF144A、MECOM、AFAP1、PDGFRA、IL6、TPCN2、NLRP6、HAO1)。
- AS与冠心病的遗传相关性为0.15(SE,0.05)(P = 1.60 × 10-3)。
- 孟德尔随机化显示血清磷酸盐是AS特异性危险因素(AS:OR,1.20;95% CI,1.11-1.31;P = 1.27 × 10-5;CAD:OR,0.97;95% CI 0.94-1.00;P = .04)。
- 孟德尔随机化还发现血压、体重指数和胆固醇代谢与AS的关联明显弱于与冠心病的关联。
临床怎么用
- 对AS患者评估心血管风险时,不宜简单套用冠心病的遗传与血脂风险框架,需关注AS特异性因素如血磷。
- 11个AS特异性位点及血磷通路可作为未来AS机制研究与靶点探索的方向。
局限性
- 研究参与者均为欧洲血统,结论外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist. However, it is unknown which genetic and cardiovascular risk factors might be AS-specific and which could be shared between AS and CAD. OBJECTIVE: To identify genetic risk loci and cardiovascular risk factors with AS-specific associations. DESIGN, SETTING, AND PARTICIPANTS: This was a genomewide association study (GWAS) of AS adjusted for CAD with participants from the European Consortium for the Genetics of Aortic Stenosis (EGAS) (recruited 2000-2020), UK Biobank (recruited 2006-2010), Estonian Biobank (recruited 1997-2019), and FinnGen (recruited 1964-2019). EGAS participants were collected from 7 sites across Europe. All participants were of European ancestry, and information on comorbid CAD was available for all participants. Follow-up analyses with GWAS data on cardiovascular traits and tissue transcriptome data were also performed. Data were analyzed from October 2022 to July 2023. EXPOSURES: Genetic variants. MAIN OUTCOMES AND MEASURES: Cardiovascular traits associated with AS adjusted for CAD. Replication was performed in 2 independent AS GWAS cohorts. RESULTS: A total of 18 792 participants with AS and 434 249 control participants were included in this GWAS adjusted for CAD. The analysis found 17 AS risk loci, including 5 loci with novel and independently replicated associations (RNF114A, AFAP1, PDGFRA, ADAMTS7, HAO1). Of all 17 associated loci, 11 were associated with risk specifically for AS and were not associated with CAD (ALPL, PALMD, PRRX1, RNF144A, MECOM, AFAP1, PDGFRA, IL6, TPCN2, NLRP6, HAO1). Concordantly, this study revealed only a moderate genetic correlation of 0.15 (SE, 0.05) between AS and CAD (P = 1.60 × 10-3). Mendelian randomization revealed that serum phosphate was an AS-specific risk factor that was absent in CAD (AS: odds ratio [OR], 1.20; 95% CI, 1.11-1.31; P = 1.27 × 10-5; CAD: OR, 0.97; 95% CI 0.94-1.00; P = .04). Mendelian randomization also found that blood pressure, body mass index, and cholesterol metabolism had substantially lesser associations with AS compared with CAD. Pathway and transcriptome enrichment analyses revealed biological processes and tissues relevant for AS development. CONCLUSIONS AND RELEVANCE: This GWAS adjusted for CAD found a distinct genetic risk profile for AS at the single-marker and polygenic level. These findings provide new targets for future AS research.
引用
- Trenkwalder T, Maj C, Al-Kassou B, et al. Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease. JAMA Cardiol. 2025. PMID: 39504041. doi:10.1001/jamacardio.2024.3738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。